Integra Lifesciences Holdings (IART) Tops Q4 EPS by 2c; Guides FY13
Integra Lifesciences Holdings (NASDAQ: IART) reported Q4 EPS of $0.78, $0.02 better than the analyst estimate ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
